Clinical Trials Directory

Trials / Completed

CompletedNCT06440096

Complete Blood Count-derived Indexes in Inflammatory Modic Changes

Harran University Hospital Department of Physical Medicine and Rehabilitation

Status
Completed
Phase
Study type
Observational
Enrollment
48 (actual)
Sponsor
Veysel Delen, MD · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Not accepted

Summary

Some indicators generated from hemogram such as neutrophil/lymphocyte (NLR) have been suggested as biomarkers of systemic inflammation. Type I Modic changes (MCs) have inflammatory nature histologically and are more painful clinically than type II MCs. Therefore, we hypothesized that patients with type I MCs may have increased inflammatory biomarkers and low back pain than those with type II MCs. The aim of this study was to test this hypothesis.

Detailed description

Patients and Methods: A total of 48 patients with MCs (type I/type II=24/24) were included in this study. Their demographic, clinical and hematologic characteristics were recorded. A 10 cm Visual Analog Scale (VAS) was used to detect low back pain intensity. Systemic inflammatory biomarkers including NLR, monocyte/lymphocyte (MLR), platelet/lymphocyte (PLR), neutrophil/lymphocyte\*platelet (NLPR), systemic inflammatory index (SII), systemic inflammatory response index (SIRI), and aggregate index of systemic inflammation (AISI) were derived from whole blood cell count. Keywords: Neutrophil-to-lymphocyte ratio, inflammation, Modic changes, back pain.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESThemogramhemogram

Timeline

Start date
2023-03-30
Primary completion
2024-01-05
Completion
2024-01-05
First posted
2024-06-03
Last updated
2024-06-03

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06440096. Inclusion in this directory is not an endorsement.